Antibodies under a microscope

DHH02211

Research Grade Camrelizumab

Description

SHR-1210, CAS: 1798286-48-2

Targets

Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279

Isotype/Mimetic

IgG4-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression